0001829049-20-000001.txt : 20201020
0001829049-20-000001.hdr.sgml : 20201020
20201020133525
ACCESSION NUMBER: 0001829049-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20201020
DATE AS OF CHANGE: 20201020
EFFECTIVENESS DATE: 20201020
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aristea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001829049
IRS NUMBER: 831074231
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-378342
FILM NUMBER: 201247909
BUSINESS ADDRESS:
STREET 1: 12770 HIGH BLUFF DRIVE
STREET 2: SUITE 380
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-987-4064
MAIL ADDRESS:
STREET 1: 12770 HIGH BLUFF DRIVE
STREET 2: SUITE 380
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
D
1
primary_doc.xml
X0708
D
LIVE
0001829049
Aristea Therapeutics, Inc.
12770 HIGH BLUFF DRIVE
SUITE 380
SAN DIEGO
CA
CALIFORNIA
92130
858-987-4064
DELAWARE
None
None
Corporation
true
2018
James
Mackay
c/o Aristea Therapeutics, Inc.
12770 HIgh Bluff Drive, Suite 380
San Diego
CA
CALIFORNIA
92130
Executive Officer
Director
Tiba
Aynechi
c/o Aristea Therapeutics, Inc.
12770 HIgh Bluff Drive, Suite 380
San Diego
CA
CALIFORNIA
92130
Director
Kenneth
Harrison
c/o Aristea Therapeutics, Inc.
12770 HIgh Bluff Drive, Suite 380
San Diego
CA
CALIFORNIA
92130
Director
Ciara
Kennedy
c/o Aristea Therapeutics, Inc.
12770 HIgh Bluff Drive, Suite 380
San Diego
CA
CALIFORNIA
92130
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-10-06
false
true
false
0
62620986
39620984
23000002
$36,999,998.14 new money; $2,620,986.30 conversion of notes
false
9
0
0
0
false
Aristea Therapeutics, Inc.
/s/ James Mackay
James Mackay
President
2020-10-20